Loading
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
Latest quote
$9.51
−$0.21 · -2.16%
After-hours
$9.51
$0.00 · 0.00%
Oct 8, 4:10 PM ET
Regular session · ET · Market data may be delayed.
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
Day range
Current $9.51
52-week range
Current $9.51
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
70
Undervalued
Sentiment
64
Bullish
Risk
64
High Risk
Momentum
38
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
Day range
Current $9.51
52-week range
Current $9.51
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 32.03M USD | 25.18M USD | 16.03M USD | 8.59M USD | 5.45M USD |
| Cost of goods sold | 4.24M USD | 3.79M USD | 2.8M USD | 1.62M USD | 1.39M USD |
| Gross profit | 27.79M USD | 21.4M USD | 13.23M USD | 6.98M USD | 4.07M USD |
| Research and development | 2.74M USD | 2.36M USD | 5.32M USD | 5.52M USD | 2.54M USD |
| Selling, general, and administrative | 38.21M USD | 31.2M USD | 26.71M USD | 24.33M USD | 21.57M USD |
| Operating expenses | 40.94M USD | 33.56M USD | 32.03M USD | 29.85M USD | 24.11M USD |
| Interest income | 298K USD | 572K USD | 433K USD | 287K USD | 11K USD |
| Interest expense | 590K USD | — | — | — | — |
| Depreciation and amortization | 1.68M USD | 1.26M USD | 1.03M USD | 596K USD | 382K USD |
| Operating income | −13.15M USD | −12.16M USD | −18.81M USD | −22.87M USD | −20.04M USD |
| Net income | −13.97M USD | −11.89M USD | −18.83M USD | −22.16M USD | −17.22M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Feb 15, 2023 | 1:15 | — | — |
Effective Feb 15, 2023
1:15
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI1.34M0.00%2.3T USD0.03%$379.56-0.39%
Vanguard Extended Market ETFVXF649.13K0.00%95.4B USD0.05%$233.13-0.15%
State Street SPDR S&P International Small Cap ETFGWX549.59K0.06%925.91M USD0.40%$45.14-0.75%
iShares Micro-Cap ETFIWC188K0.01%1.33B USD0.60%$182.79-0.31%Vanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFState Street SPDR S&P International Small Cap ETFGWXiShares Micro-Cap ETFIWCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
